Exane Asset Management boosted its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 41.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 4,678 shares of the medical instruments supplier’s stock after purchasing an additional 1,368 shares during the period. Exane Asset Management’s holdings in DENTSPLY SIRONA were worth $205,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of XRAY. Piedmont Investment Advisors LLC acquired a new position in DENTSPLY SIRONA during the second quarter worth about $117,000. Qube Research & Technologies Ltd purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $134,000. Cornerstone Wealth Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $202,000. HRT Financial LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $207,000. Finally, Cambridge Investment Research Advisors Inc. purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $209,000. Institutional investors and hedge funds own 97.62% of the company’s stock.
Several equities analysts recently issued reports on the stock. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Thursday, September 27th. ValuEngine downgraded shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Tuesday, September 4th. HC Wainwright set a $40.00 price objective on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a research note on Friday, August 31st. TheStreet downgraded shares of DENTSPLY SIRONA from a “c-” rating to a “d+” rating in a research note on Tuesday, August 14th. Finally, Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 9th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $52.18.
XRAY traded up $0.19 during trading hours on Friday, reaching $35.87. 2,241,844 shares of the stock traded hands, compared to its average volume of 2,663,035. The firm has a market cap of $8.39 billion, a price-to-earnings ratio of 13.48, a PEG ratio of 2.18 and a beta of 1.21. DENTSPLY SIRONA Inc has a fifty-two week low of $35.30 and a fifty-two week high of $68.98. The company has a current ratio of 1.69, a quick ratio of 1.10 and a debt-to-equity ratio of 0.31.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.01. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same period last year, the business earned $0.65 EPS. On average, analysts forecast that DENTSPLY SIRONA Inc will post 2.08 earnings per share for the current fiscal year.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Recommended Story: Book Value Per Share – BVPS
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.